Dr. Hays is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2050 Kenny Rd
Tower 8th Floor
Columbus, OH 43221Phone+1 614-293-6529Fax+1 614-293-9469- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Wake Forest University School of MedicineResidency, Internal Medicine, 2005 - 2008
University of Texas Medical Branch School of MedicineClass of 2005
Certifications & Licensure
OH State Medical License 2012 - 2024
MD State Medical License 2008 - 2012
NC State Medical License 2005 - 2008
Clinical Trials
- TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors Start of enrollment: 2014 May 20
- A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors Start of enrollment: 2018 Oct 25
Publications & Presentations
PubMed
- Current cannabis use and pain management among US cancer patients.Krok-Schoen, J., Plascak, J., Newton, A., Strassels, S., Adib, A., Adley, N., Wagener, T., Stevens, E., Brasky, T., Hays, J.> ;Supportive Care in Cancer. 2024 Jan 18
- Associations of Cancer Patients' Demographic and Clinical Characteristics With Cannabis-Related Interest and Behaviors.Adley, N., Brasky, T., Conroy, S., Newton, A., Plascak, J., Strassels, S., Krok-Schoen, J., Hays, J.> ;Journal of Palliative Medicine. 2024 Mar 1
- 3 citationsMarijuana and Cannabidiol Use Prevalence and Symptom Management Among Patients with Cancer.Theodore M Brasky, Alison M Newton, Sara Conroy, Anita Adib, Neema C Adley, Scott A Strassels, John L Hays, Ziva D Cooper, Theodore L Wagener, Erin Stevens, Jesse J Pl...> ;Cancer Research Communications. 2023 Sep 22
- Join now to see all
Journal Articles
- The Omics Revolution Continues: The Maturation of High-Throughput Biological Data SourcesJames L Chen, John L Hays, Yearbook of Medical Informatics
- Loss of TXNIP Enhances Peritoneal Metastasis and Can Be Abrogated by Dual TORC1/2 InhibitionDavid Cohen, James L Chen, John L Hays, Oncotarget
- Early closure for safety: A phase II clinical trial of polyethylene glycol conjugated L-asparaginase in patients with advanced ovarian cancer6. Hays, J.L., Kim, G., Annunziata, C.M., Lee, J-m. Squires, J., Houston, N., and Kohn, E.C., Molecular and Clinical Oncology, 3/20/2013
Press Mentions
Dr. Hays on Immunotherapy in Ovarian Cancer TreatmentJanuary 14th, 2020
Foundation DonationMarch 2nd, 2017
NCCN Awards Research Grants to Eight Investigators to Support Clinical and Pre-Clinical Studies of Mirvetuximab Soravtansine in Various CancersJune 6th, 2016- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
The OSUCCC - JamesColumbus, Ohio
Ohio State University Wexner Medical CenterColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
